JAMP-FOSINOPRIL 20 MG — DIN 02331012
FOSINOPRIL SODIUM : 20 MG · JAMP PHARMA CORPORATION · TABLET · wholesale supply in Canada
Health Canada status: DORMANT
What is JAMP-FOSINOPRIL?
JAMP-FOSINOPRIL 20 MG contains FOSINOPRIL SODIUM : 20 MG. It is listed in the Health Canada Drug Product Database under DIN 02331012, held by JAMP PHARMA CORPORATION, supplied as TABLET for ORAL administration. Health Canada currently lists it as dormant, status dated 07-Aug-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
How much does Fosinopril cost around the world?
Fosinopril is listed on 9 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Czechia publishes a max producer price (ex-factory). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 3 | 18 | USD███.██ |
| Italy | prezzo al pubblico (classe A) | 5 | 7 | EUR███.██ |
| Australia | ex-manufacturer | 3 | 4 | AUD███.██ |
| South Africa | single exit price | 2 | 3 | ZAR███.██ |
| Austria | KVP (Kassenverkaufspreis) | 2 | 2 | EUR███.██ |
| Czechia | max producer price (ex-factory) | 1 | 2 | CZK███.██ |
| Spain | PVP con IVA (public price) | 2 | 2 | EUR███.██ |
| Hungary | producer price (ex-factory) | 2 | 2 | HUF███.██ |
| Romania | max producer price | 2 | 2 | RON███.██ |
42 pack listings across 22 brand entries and 9 price bases, refreshed 08 Sep 2026. Ranges span every Fosinopril pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Fosinopril in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
15 holders have a Canadian DIN containing Fosinopril, across 32 DINs, of which 6 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| APOTEX INC | 2 | 2 | APO-FOSINOPRIL | Sourceable in Canada |
| SANIS HEALTH INC | 2 | 2 | FOSINOPRIL | Sourceable in Canada |
| TEVA CANADA LIMITED | 2 | 2 | TEVA-FOSINOPRIL | Sourceable in Canada |
| RANBAXY PHARMACEUTICALS CANADA INC. | 4 | 0 | FOSINOPRIL TABLETS, RAN-FOSINOPRIL | No marketed DIN |
| LABORATOIRE RIVA INC. | 2 | 0 | RIVA-FOSINOPRIL | No marketed DIN |
| LINSON PHARMA CO. | 2 | 0 | LIN-FOSINOPRIL | No marketed DIN |
| MYLAN PHARMACEUTICALS ULC | 2 | 0 | MYLAN-FOSINOPRIL | No marketed DIN |
| NU-PHARM INC | 2 | 0 | NU-FOSINOPRIL | No marketed DIN |
| PHARMASCIENCE INC | 2 | 0 | PMS-FOSINOPRIL | No marketed DIN |
| PHARMEL INC | 2 | 0 | PHL-FOSINOPRIL | No marketed DIN |
| PRO DOC LIMITEE | 2 | 0 | FOSINOPRIL-10, FOSINOPRIL-20 | No marketed DIN |
| RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | 2 | 0 | RATIO FOSINOPRIL | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 20 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Fosinopril |
|---|---|
| ATC code | C09AA09 |
| AHFS class | 24:32.04 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02331012 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2331012 |
| Brand name | JAMP-FOSINOPRIL |
| Generic / active ingredient | FOSINOPRIL SODIUM : 20 MG |
| Market authorization holder | JAMP PHARMA CORPORATION |
| Health Canada schedule | Prescription |
| ATC code | C09AA09 |
| ATC anatomical main group | C — Cardiovascular system |
| ATC therapeutic subgroup | C09AA |
| Current status | DORMANT |
| Status date | 07-Aug-2017 |
| Original market date | 2010-05-17 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
6 of 32 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-FOSINOPRIL | 10 MG | TABLET | APOTEX INC | MARKETED | 02266008 |
| APO-FOSINOPRIL | 20 MG | TABLET | APOTEX INC | MARKETED | 02266016 |
| FOSINOPRIL | 10 MG | TABLET | SANIS HEALTH INC | MARKETED | 02459388 |
| FOSINOPRIL | 20 MG | TABLET | SANIS HEALTH INC | MARKETED | 02459396 |
| TEVA-FOSINOPRIL | 20 MG | TABLET | TEVA CANADA LIMITED | MARKETED | 02247803 |
| TEVA-FOSINOPRIL | 10 MG | TABLET | TEVA CANADA LIMITED | MARKETED | 02247802 |
| AVA-FOSINOPRIL | 20 MG | TABLET | AVANSTRA INC | CANCELLED POST MARKET | 02363739 |
| AVA-FOSINOPRIL | 10 MG | TABLET | AVANSTRA INC | CANCELLED POST MARKET | 02363720 |
| FOSINOPRIL TABLETS | 20 MG | TABLET | RANBAXY PHARMACEUTICALS CANADA INC. | CANCELLED PRE MARKET | 02332574 |
| FOSINOPRIL TABLETS | 10 MG | TABLET | RANBAXY PHARMACEUTICALS CANADA INC. | CANCELLED PRE MARKET | 02332566 |
2 · Same class — other molecules in ATC C09AA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Ramipril | ACH-RAMIPRIL · ACT RAMIPRIL · AG-RAMIPRIL · ALTACE · +37 more | 171 | 55 | Yes |
| Perindopril | AG-PERINDOPRIL · AG-PERINDOPRIL ERBUMINE · APO-PERINDOPRIL · APO-PERINDOPRIL ARGININE · +20 more | 81 | 54 | Yes |
| Enalapril | ACT ENALAPRIL · APO-ENALAPRIL · AVA-ENALAPRIL · DOM-ENALAPRIL · +21 more | 100 | 36 | Yes |
| Trandolapril | APO-TRANDOLAPRIL · AURO-TRANDOLAPRIL · MAVIK · MYLAN-TRANDOLAPRIL · +4 more | 40 | 25 | Yes |
| Lisinopril | ACT LISINOPRIL · APO-LISINOPRIL · APO-LISINOPRIL TABLET (TYPE P) - 10MG · APO-LISINOPRIL TABLET (TYPE P) - 20MG · +28 more | 99 | 15 | Yes |
| Captopril | APO-CAPTO TAB 100MG · APO-CAPTO TAB 12.5MG · APO-CAPTO TAB 25MG · APO-CAPTO TAB 50MG · +41 more | 77 | 9 | Yes |
| Cilazapril | APO-CILAZAPRIL · CILAZAPRIL · CO CILAZAPRIL · DOM-CILAZAPRIL · +7 more | 33 | 6 | Yes |
| Fosinopril | APO-FOSINOPRIL · AVA-FOSINOPRIL · FOSINOPRIL · FOSINOPRIL TABLETS · +14 more | 32 | 6 | Yes |
| Quinapril | ACCUPRIL 5MG TAB · ACCUPRIL TAB 10MG · ACCUPRIL TAB 20MG · ACCUPRIL TAB 40MG · +7 more | 32 | 6 | Yes |
| Benazepril | BENAZEPRIL · LOTENSIN 10MG · LOTENSIN 20MG · LOTENSIN 5MG · +1 more | 9 | 3 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is JAMP-FOSINOPRIL called?
The same molecule, Fosinopril, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| APO-Fosinopril | Latin | Australia |
| MONACE COMBI | Latin | Czechia |
| Monopril | Latin | South Africa |
| Fosicomb Tabl. | Latin | Austria |
| Monozide | Latin | South Africa |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.